CD55
Showing 1 - 25 of 3,096
CD55-deficient Protein-losing Enteropathy, CHAPLE Trial in Bethesda, Pathum Wan, Istanbul (Pozelimab)
Active, not recruiting
- CD55-deficient Protein-losing Enteropathy
- CHAPLE
-
Bethesda, Maryland
- +2 more
Nov 8, 2022
Paroxysmal Nocturnal Hemoglobinuria (PNH), CD55-deficient Protein-losing Enteropathy (PLE), CD59 Deficiency Trial (Pozelimab)
Available
- Paroxysmal Nocturnal Hemoglobinuria (PNH)
- +2 more
- (no location specified)
Jan 28, 2022
Philadelphia Chromosome-negative or BCR-ABL-negative, CD19-positive ALL Trial in Spain (blinatumomab)
Terminated
- Philadelphia Chromosome-negative or BCR-ABL-negative, CD19-positive ALL
-
Badalona, Barcelona, Spain
- +11 more
Jul 26, 2022
CD55 - Cluster of Differentiation Antigen 55 Deficiency, Primary Intestinal Lymphangiectasis, Protein-Losing Enteropathies Trial
Unknown status
- CD55 - Cluster of Differentiation Antigen 55 Deficiency
- +3 more
- Eculizumab Injection
-
Istanbul, TurkeyMarmara University
Aug 13, 2019
Multiple Myeloma Trial in Amsterdam (all-trans retinoic acid (ATRA))
Active, not recruiting
- Multiple Myeloma
- all-trans retinoic acid (ATRA)
-
Amsterdam, NH, NetherlandsVU University Medical Center
May 5, 2022
Erythrocytosis, Erythropoiesis Abnormal Trial in Copenhagen (Recombinant human erythropoietin)
Completed
- Erythrocytosis
- Erythropoiesis Abnormal
- Recombinant human erythropoietin
-
Copenhagen, DenmarkDepartment of Nutrition, Exercise and Sports
Apr 25, 2023
Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Breast Carcinoma Trial in
Not yet recruiting
- Anatomic Stage III Breast Cancer AJCC v8
- +14 more
- Biopsy
- +25 more
-
Portland, OregonOHSU Knight Cancer Institute
Jul 12, 2022
Hematological Disorders Associated With COVID-19 Infection
Completed
- Hematological Condition With COVID19
-
Assiut, EgyptFacility of medicine
Jan 6, 2023
Rheumatoid Arthritis Trial in Los Angeles, Chicago, London (Tc 99m tilmanocept)
Recruiting
- Rheumatoid Arthritis
- Tc 99m tilmanocept
-
Los Angeles, California
- +3 more
Sep 13, 2022
Rhizarthrosis Trial in Champigny-sur-Marne (collecting a Nanofat-type microfat autograft)
Completed
- Rhizarthrosis
- collecting a Nanofat-type microfat autograft
-
Champigny-sur-Marne, FranceHôpital Privé Paul d'Egine
Jun 22, 2023
Pharmacodynamics of Eculizumab in Paroxysmal Nocturnal
Completed
- Paroxysmal Nocturnal Hemoglobinuria
- +2 more
- Blood collection for measurement of eculizumab peak concentrations
-
Nijmegen, NetherlandsRadboudumc
Aug 23, 2022
Psoriasis Trial in Sohag (skin biopsy)
Not yet recruiting
- Psoriasis
- skin biopsy
-
Sohag, EgyptSohag university Hospital
Sep 21, 2023
Cervical Dystonia, Primary, Blepharospasm Trial in La Tronche (other, drug, diagnostic test)
Completed
- Cervical Dystonia, Primary
- Blepharospasm
- Treadmill
- +2 more
-
La Tronche, Isere, FranceCHU Grenoble Alpes
Jan 6, 2023
SARS-CoV, SARS-CoV-2 Trial in Decatur, Baltimore, Rochester (VXCO-100)
Recruiting
- SARS-CoV
- SARS-CoV-2
- VXCO-100
-
Decatur, Georgia
- +2 more
May 19, 2023
Cervical Dystonia Trial in Russian Federation, United States (Botulinum toxin type A, Placebo)
Completed
- Cervical Dystonia
- Botulinum toxin type A
- Placebo
-
Phoenix, Arizona
- +21 more
Sep 15, 2022
Cervical Dystonia Trial in Worldwide (Botulinum toxin type A, Placebo)
Completed
- Cervical Dystonia
- Botulinum toxin type A
- Placebo
-
Clayton, Australia
- +56 more
Sep 15, 2022
Paroxysmal Nocturnal Hemoglobinuria Trial in China
Recruiting
- Paroxysmal Nocturnal Hemoglobinuria
-
Hefei, Anhui, China
- +23 more
Nov 23, 2023
HIV-1-infection Trial in Argentina, Brazil (Intervention Arm: dolutegravir/lamivudine, Comparator ARM: TDF/XTC plus Dolutegravir
Recruiting
- HIV-1-infection
- Intervention Arm: dolutegravir/lamivudine
- Comparator ARM: TDF/XTC plus Dolutegravir (XTC stand for lamivudine OR emtricitabine)
-
Ciudad Autonoma de Buenos Aire, Buenos Aires, Argentina
- +7 more
Jun 29, 2022
Liver Failure, Acute on Chronic Trial in Guangzhou (MSC-EV)
Not yet recruiting
- Liver Failure, Acute on Chronic
- MSC-EV
-
Guangzhou, Guangdong, ChinaThird Affiliated Hospital, Sun Yat-Sen University
May 30, 2023
Comparison of Three Robotic Platforms for Hysterectomy
Not yet recruiting
- Hysterectomy
- Robotic-assisted hysterectomy
-
Verona, ItalyAOUI Verona - University of Verona - Department of Obstetrics an
Nov 15, 2023
NSCLC Trial (Phase I - Mirdametinib - Level 1, Phase II - Mirdametinib, Phase I - Mirdametinib - Level 2)
Not yet recruiting
- Non-Small Cell Lung Cancer
- Phase I - Mirdametinib - Level 1
- +4 more
- (no location specified)
Jul 7, 2023
TRansmural hEaliNg Definition in CroHn's Disease (TRENCH 1)
Not yet recruiting
- Crohn Disease
- Magnetic Resonance Enterography (MRE)
-
Liège, Belgium
- +17 more
Jun 5, 2023